These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1331597)

  • 1. [Clinical significance of oncogene product expression in human lung cancer].
    Dosaka-Akita H; Harada M; Miyamoto H; Kawakami Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug; 30(8):1441-7. PubMed ID: 1331597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.
    Miyamoto H; Harada M; Isobe H; Akita HD; Haneda H; Yamaguchi E; Kuzumaki N; Kawakami Y
    Cancer Res; 1991 Dec; 51(23 Pt 1):6346-50. PubMed ID: 1657384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
    Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
    Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung.
    Spandidos DA; Zakinthinos S; Petraki C; Sotsiou F; Yiagnisis M; Dimopoulos AM; Roussos C; Field JK
    Anticancer Res; 1990; 10(5A):1105-14. PubMed ID: 2173469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expressions of N-myc and ras oncogene products in neuroblastoma and their correlations with prognosis.
    Nakada K; Fujioka T; Kitagawa H; Takakuwa T; Yamate N
    Jpn J Clin Oncol; 1993 Jun; 23(3):149-55. PubMed ID: 8350488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
    Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
    Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal deletion, gene amplification, alternative processing, and autocrine growth factor production in the pathogenesis of human lung cancer.
    Minna JD; Battey JF; Birrer M; Brooks BJ; Cuttitta F; DeGreve J; Gazdar AF; Johnson BE; Nau MM; Sausville EA
    Princess Takamatsu Symp; 1986; 17():109-22. PubMed ID: 3332004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung.
    Komiya T; Hosono Y; Hirashima T; Masuda N; Yasumitsu T; Nakagawa K; Kikui M; Ohno A; Fukuoka M; Kawase I
    Clin Cancer Res; 1997 Oct; 3(10):1831-5. PubMed ID: 9815570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human lung cancers growing on extracellular matrix: expression of oncogenes and growth factors.
    Pavelic K; Antonic M; Pavelic L; Pavelic J; Pavelic Z; Spaventi S
    Anticancer Res; 1992; 12(6B):2191-6. PubMed ID: 1363516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations.
    Volm M; Efferth T; Mattern J
    Anticancer Res; 1992; 12(1):11-20. PubMed ID: 1348920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
    Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
    Hommura F; Dosaka-Akita H; Mishina T; Nishi M; Kojima T; Hiroumi H; Ogura S; Shimizu M; Katoh H; Kawakami Y
    Clin Cancer Res; 2000 Oct; 6(10):4073-81. PubMed ID: 11051259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis.
    Vora HH; Shah NG; Patel DD; Trivedi TI; Chikhlikar PR
    J Surg Oncol; 2003 Jan; 82(1):34-50. PubMed ID: 12501167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of p53 and ras p21 protein expression in surgically treated non-small cell lung carcinoma.
    Cohen R; Guber A; Koren R; Marom Z; Siegal A
    Rom J Morphol Embryol; 1998; 44(1-4):117-23. PubMed ID: 15678852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemical study of RAS oncoprotein in cytologic specimens of primary lung tumours.
    Koutselini H; Kappatou G; Yiagnisis M; Field JK; Spandidos DA
    Anticancer Res; 1990; 10(3):597-603. PubMed ID: 2164347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.
    Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K
    Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of the expression of ras oncogene product in non-small cell lung cancer.
    Harada M; Dosaka-Akita H; Miyamoto H; Kuzumaki N; Kawakami Y
    Cancer; 1992 Jan; 69(1):72-7. PubMed ID: 1309311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
    Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
    Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
    Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M
    Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.